Cerence Is Priced Fairly; Patient Investors May Locate Buying Opportunities Over Next 12 Months – Cerence Inc. (NASDAQ:CRNC)


Synopsis Cerence (CRNC) is composed of its dominant, extremely profitable, low-to-mid single digit growth Edge business, and its nascent, rapidly expanding, likely loss-making Connected Services segment. Cerence currently trades at around $21.50 per share. I estimate that the Edge business is worth approximately $13-20 per share. I advise that CerenceRead More →

Woodford Patient Capital shares fall 1.7% By Reuters


© Reuters. Woodford Patient Capital shares fall 1.7% LONDON (Reuters) – Shares in Woodford Patient Capital Trust (WPCT), Woodford Investment Management’s only listed fund, fell 1.7% at the open on Wednesday after the Financial Times reported it may drop Neil Woodford as manager. Woodford Investment Management suspended its flagship 3.7Read More →

Tabula Rasa HealthCare Acquires PrescribeWellness For Patient CRM Tech – Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)


Quick Take Tabula Rasa HealthCare (TRHC) announced it has acquired PrescribeWellness for $150 million. PrescribeWellness provides cloud-based patient relationship management services. TRHC is gaining a number of pharmacy-centric capabilities with this complementary acquisition at a reasonable price. Target Company Irvine, California-based PrescribeWellness was founded in 2010 to ‘inspire collaboration amongRead More →